TP53 and cancer: Apigenin, on the other hand reduces neuronal damage through its antioxidative and antiapoptotic properties affecting the expression of p53 and Nrf2, as well as the transcription of their target genes, thus strengthening its candidature as a potential protective and therapeutic aid to do away with CNS ailments including cancer [177].